Company Profile
Founded in January 2011, Suzhou Jinghong Biotechnology Co., Ltd. is a leading biological and pharmaceutical company focusing on process R&D on a variety of innovative drugs, natural products, APIs / generic drugs, and corresponding key intermediates. The company is located in the Science and Technology Park of Wujiang District, Suzhou, with over 1,700 m2 of laboratory and office space.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(-)-Huperzine A |
5,9-Methanocycloocta[b]pyridin-2(1H)-one,5-amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-,(5R,9R,11E)-;5,9-Methanocycloocta[b]pyridin-2(1H)-one,5-amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-,[5R-(5α,9β,11E)]-;Selagine;(5R,9R,11E)-5-Amino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-5,9-methanocycloocta[b]pyridin-2(1H)-one;Huperzine A;(-)-Huperzine A;(-)-Selagine;Kimpukan A;Hupzine A;Hup A;Huperzine;116-28-9;1369-64-8;475473-11-1 |
102518-79-6 | Inquiry | |
(4R)-13-[[2-O-(β-D-Glucopyranosyl)-3-O-(β-D-glucopyranosyl)-β-D-glucopyranosyl]oxy]kaur-16-en-18-oic acid 2-O-(β-D-glucopyranosyl)-β-D-glucopyranosyl ester |
Kaur-16-en-18-oic acid,13-[(O-β-D-glucopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→3)]-β-D-glucopyranosyl)oxy]-,2-O-β-D-glucopyranosyl-β-D-glucopyranosyl ester,(4α)-;Rebaudioside D |
63279-13-0 | Inquiry | |
(Z)-2-(2-Aminothiazol-4-yl)-N-(2,2-dihydroxyethyl)-2-(hydroxyimino)acetamide |
178422-40-7 | Inquiry | ||
Cefdinir Lactone |
Cefdinir Lactone;(αZ)-2-AMino-α-(hydroxyiMino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-3-Methyl-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-4-thiazoleacetaMide;Cefdinir Lactone Discontinued;(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)-N-{(3RS,5aR,6R)-3-methyl-1,7-dioxo-1,3,4,5a,6,7- hexahydroazeto [2,1-b]furo[3,4-d][1,3]thiazin-6-yl}acetamide |
946573-41-7 | Inquiry | |
Dasatinib Impurity 1 |
5-Thiazolecarboxamide,2-amino-N-(2-chloro-6-methylphenyl)-;2-Amino-N-(2-chloro-6-methylphenyl)-5-thiazolecarboxamide;2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide;2-Amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide |
302964-24-5 | Inquiry | |
Dasatinib Impurity 2 |
N-(2-Chloro-6-methylphenyl)-2-[[2-methyl-6-(1-piperazinyl)-4-pyrimidinyl]amino]-5-thiazolecarboxamide;N-Deshydroxyethyl Dasatinib;Dasatinib Impurity A;Dasatinib N-Deshydroxyethyl Impurity;Dasatinib metabolite M4;M4 BMS582691;N-(2-chloro-6-methylphenyl)-2-[(2-methyl-6-piperazin-1-ylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide;N-(2-CHLORO-6-METHYLPHENYL)-2-{[2-METHYL-6-(PIPERAZIN-1-YL)PYRIMIDIN-4-YL]AMINO}-1,3-THIAZOLE-5-CARB |
910297-51-7 | Inquiry | |
Dasatinib Impurity 3 |
Dasatinib N-Oxide;Dasatinib metabolite M5;UNII-B16WQA6880;B16WQA6880;N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-4-oxido-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide;SCHEMBL1704309;CTK8F8967;DTXSID50474434;BCP14228;ZINC22055426 |
910297-52-8 | Inquiry | |
Dasatinib Impurity 4 |
1184919-23-0 | Inquiry | ||
Dasatinib Impurity 5 |
302962-43-2 | Inquiry | ||
REBAUDIOSIDE M |
Rebaudioside M;(4alpha)-13-[(O-beta-D-Glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl)oxy]-kaur-16-en-18-oic acid O-beta-D-glucopyranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl ester;Rebaudioside X |
1220616-44-3 | Inquiry |
CONTACT INFORMATION
Sign In for Details